Cargando…

Biomarkers identified for prostate cancer patients through genome-scale screening

Prostate cancer is a threat to men and usually occurs in aged males. Though prostate specific antigen level and Gleason score are utilized for evaluation of the prostate cancer in clinic, the biomarkers for this malignancy have not been widely recognized. Furthermore, the outcome varies across indiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lei-Yun, Cui, Jia-Jia, Zhu, Tao, Shao, Wei-Hua, Zhao, Yi, Wang, Sai, Zhang, Yu-Peng, Wu, Ji-Chu, Zhang, Le
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696163/ https://www.ncbi.nlm.nih.gov/pubmed/29190897 http://dx.doi.org/10.18632/oncotarget.20739

Ejemplares similares

Large-scale RNAi screen identified Dhpr as a regulator of mitochondrial morphology and tissue homeostasis
por: Zhou, Jia, et al.
Publicado: (2019)

Proteomic screening identifies RPLp2 as a specific regulator for the translation of coronavirus
por: Dong, Hui-Jun, et al.
Publicado: (2023)

High-throughput drug screening identifies fluoxetine as a potential therapeutic agent for neuroendocrine prostate cancer
por: Chen, Lei, et al.
Publicado: (2023)

Phosphoproteomics Identifies Significant Biomarkers Associated with the Proliferation and Metastasis of Prostate Cancer
por: Xu, Rongfang, et al.
Publicado: (2021)

Identifying novel selective PPO inhibitors through structure-based virtual screening and bio-evaluation
por: Zhao, Shan-Shan, et al.
Publicado: (2023)

Serum multi-cytokines screening identifies TRAIL and IL-10 as probable new biomarkers for prostate health index diagnostic utility adjustment in grey zone aggressive prostate cancer detection: A single-center data in China
por: Chen, Haojie, et al.
Publicado: (2022)

Clinical Applications of Liquid Biopsy in Prostate Cancer: From Screening to Predictive Biomarker
por: Ionescu, Filip, et al.
Publicado: (2022)

Genome-scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma
por: Wei, Hao-Tang, et al.
Publicado: (2018)

Prostate cancer – a biomarker perspective
por: Liu, Yanqiu, et al.
Publicado: (2012)

Plasma Messenger RNAs Identified Through Bioinformatics Analysis are Novel, Non-Invasive Prostate Cancer Biomarkers
por: Wang, Rui, et al.
Publicado: (2020)

CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancer
por: Lei, Hanqi, et al.
Publicado: (2021)

Identification of novel biomarkers of prostate cancer through integrated analysis
por: Zhang, Pu, et al.
Publicado: (2021)

Serum peptidomic screening identified circulating peptide biomarkers predictive for preeclampsia
por: Zhao, Shenglong, et al.
Publicado: (2022)

Potential Epigenetic Biomarkers for Prostate Cancer Screening
por: Bae, Jong-Myon
Publicado: (2018)

Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis
por: Zhang, Jingjing, et al.
Publicado: (2022)

Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer
por: Wang, Meilin, et al.
Publicado: (2015)

Phage display screening identifies a prostate specific antigen (PSA)(–/lo) prostate cancer cell specific peptide to retard castration resistance of prostate cancer
por: Sui, Yi, et al.
Publicado: (2021)

LncRNA weighted gene co-expression network analysis reveals novel biomarkers related to prostate cancer metastasis
por: Liu, Miao, et al.
Publicado: (2022)

Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular Carcinoma
por: Zhang, Qifan, et al.
Publicado: (2021)

Large-scale chemical screen identifies Gallic acid as a geroprotector for human stem cells
por: Shan, Hezhen, et al.
Publicado: (2021)

Serum Metabolic Profiling Identifies a Biomarker Panel for Improvement of Prostate Cancer Diagnosis
por: Xu, Huan, et al.
Publicado: (2021)

A robust photoluminescence screening assay identifies uracil-DNA glycosylase inhibitors against prostate cancer
por: Li, Guodong, et al.
Publicado: (2020)

Association of molecular biomarkers expression with biochemical recurrence in prostate cancer through tissue microarray immunostaining
por: MA, DING, et al.
Publicado: (2015)

Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)
por: Stephan, Carsten, et al.
Publicado: (2014)

Identifying Mitochondrial-Related Genes NDUFA10 and NDUFV2 as Prognostic Markers for Prostate Cancer through Biclustering
por: Zhang, Haokun, et al.
Publicado: (2021)

Screening for biomarkers reflecting the progression of Babesia microti infection
por: Xu, Bin, et al.
Publicado: (2018)

Periostin identified as a potential biomarker of prostate cancer by iTRAQ-proteomics analysis of prostate biopsy
por: Sun, Chuanyu, et al.
Publicado: (2011)

Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa
por: Zhang, Liyun, et al.
Publicado: (2021)

Screening of urine identifies PLA2G16 as a field defect methylation biomarker for prostate cancer detection
por: Jarrard, William E., et al.
Publicado: (2019)

miR-145-5p: A Potential Biomarker in Predicting Gleason Upgrading of Prostate Biopsy Samples Scored 3+3=6
por: Wang, Tao, et al.
Publicado: (2021)

Identifying Drug Candidates for COVID-19 with Large-Scale Drug Screening
por: Wu, Yifei, et al.
Publicado: (2023)

Screening of Breast Cancer Methylation Biomarkers Based on the TCGA Database
por: Wang, Xuechun, et al.
Publicado: (2021)

A practical method to screen and identify functioning biomarkers in nasopharyngeal carcinoma
por: Liu, Chengyou, et al.
Publicado: (2021)

Identifying prognostic signatures in the microenvironment of prostate cancer
por: Lu, Guoliang, et al.
Publicado: (2021)

Tissue‐based quantitative proteomics to screen and identify the potential biomarkers for early recurrence/metastasis of esophageal squamous cell carcinoma
por: Cai, Xu‐Wei, et al.
Publicado: (2018)

Biomarkers for Prostate Cancer: From Diagnosis to Treatment
por: Chen, Jia-Yan, et al.
Publicado: (2023)

Is geriatric depression scale a valid instrument to screen depression in Chinese community-dwelling elderly?
por: Huang, Feifei, et al.
Publicado: (2021)

Large‐scale plasma proteomic profiling identifies a high‐performance biomarker panel for Alzheimer's disease screening and staging
por: Jiang, Yuanbing, et al.
Publicado: (2021)

Prostate stem cells identified
por: LeBrasseur, Nicole
Publicado: (2002)

Screening circulating proteins to identify biomarkers of fetal macrosomia
por: Cruickshank, Tess, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q0ad4aogc7il816dbk3o7opv1l